Henry M, Leick M, Florescu DF, Keck M. Valganciclovir for the treatment of cytomegalovirus infections in pediatric intestinal transplant recipients: A case series. Pediatr Transplant 2021;25:e14034. [PMID: 34081375 DOI: 10.1111/petr.14034][Reference Citation Analysis]
3
Wang J, van den Anker JN, Burckart GJ. Progress in Drug Development-Pediatric Dose Selection: Workshop Summary. J Clin Pharmacol 2021;61 Suppl 1:S13-21. [PMID: 34185909 DOI: 10.1002/jcph.1828][Reference Citation Analysis]
4
Ke C, You X, Lin C, Chen J, Guo G, Wu W, Ye L, Huang P. Development of Physiologically Based Pharmacokinetic Model for Pregabalin to Predict the Pharmacokinetics in Pediatric Patients with Renal Impairment and Adjust Dosage Regimens: PBPK Model of Pregabalin in Pediatric Patients with Renal Impairment. J Pharm Sci 2021:S0022-3549(21)00561-X. [PMID: 34706283 DOI: 10.1016/j.xphs.2021.10.026][Reference Citation Analysis]
5
Minotti C, Barbieri E, Doni D, Impieri C, Giaquinto C, Donà D. Anti-infective Medicines Use in Children and Neonates With Pre-existing Kidney Dysfunction: A Systematic Review. Front Pediatr 2022;10:868513. [DOI: 10.3389/fped.2022.868513][Reference Citation Analysis]
